In addition, the IM-stimulated adipocytes secreted adiponectin, that might account for the improved glucose and lipid metabolism in CML patients concurrently affected by type 2 diabetes treated with IM [177–180]. This evidence concerns the gene ADIPOQ and chronic myelogenous leukemia, BCR-ABL1 positive.